Up a level |
Din, Shahida, Kent, Alexandra, Pollok, Richard C, Meade, Susanna, Kennedy, Nicholas A, Arnott, Ian, Beattie, R Mark, Chua, Felix, Cooney, Rachel, Dart, Robin J et al (show 24 more authors)
(2020)
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel.
GUT, 69 (10).
pp. 1769-1777.
Kennedy, Nicholas A, Jones, Gareth-Rhys, Lamb, Christopher A, Appleby, Richard, Arnott, Ian, Beattie, R Mark, Bloom, Stuart, Brooks, Alenka J, Cooney, Rachel, Dart, Robin J et al (show 26 more authors)
(2020)
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
GUT, 69 (6).
pp. 984-990.
Wilson, Bridgette, Kanno, Tokuwa, Slater, Rachael, Rossi, Megan, Irving, Peter M, Lomer, Miranda C, Probert, Chris ORCID: 0000-0003-0477-6714, Mason, A James and Whelan, Kevin
(2023)
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 58 (4).
pp. 404-416.
Probert, Christopher SJ ORCID: 0000-0003-4550-0239, Sebastian, Shaji, Gaya, Daniel R, Hamlin, P John, Gillespie, Gillian, Rose, Anita, Tate, Helen, Wheeler, Colin, Irving, Peter M, Probert, C et al (show 28 more authors)
(2018)
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis).
BMJ OPEN GASTROENTEROLOGY, 5 (1).
e000212-.
Rossi, Megan, Aggio, Raphael, Staudacher, Heidi, Lomer, Miranda, Lindsay, James O, Irving, Peter M, Probert, Chris ORCID: 0000-0003-4550-0239 and Whelan, Kevin
(2017)
VOLATILE ORGANIC COMPOUNDS PREDICT RESPONSE TO BOTH LOW FODMAP DIET AND PROBIOTICS IN IRRITABLE BOWEL SYNDROME: A RANDOMISED CONTROLLED TRIAL.
.
Noor, Nurulamin M ORCID: 0000-0003-3426-6408, Lee, James C ORCID: 0000-0001-5711-9385, Bond, Simon ORCID: 0000-0003-2528-1040, Dowling, Francis, Brezina, Biljana, Patel, Kamal V, Ahmad, Tariq, Banim, Paul J, Berrill, James W, Cooney, Rachel et al (show 33 more authors)
(2024)
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
The lancet. Gastroenterology & hepatology.
S2468-1253(24)00034-7-.